Actinium Pharmaceuticals Announces Multiple Posters/Abstracts Accepted for 59th Annual American Society of Hematology Meeting Highlighting Company’s Drug Candidates and Technology Platform Nov 1, 2017
Actinium Pharmaceuticals Announces Activation of Fifteenth Clinical Trial Site in the Phase 3 SIERRA Trial for Iomab-B Oct 25, 2017
Actinium Pharmaceuticals Provides Update on Actimab-A Phase 2 Clinical Trial for Patients with Acute Myeloid Leukemia Oct 4, 2017
Actinium Pharmaceuticals to Participate in American Society for Blood and Marrow Transplantation 2017 Corporate Council Meeting Sep 20, 2017
Actinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual Meeting Sep 13, 2017
Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017 Aug 9, 2017
Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock Aug 2, 2017
Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Jul 28, 2017
